This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.
Clinical trial NCT01304277 · COMPLETED
Trial details
- NCT number
- NCT01304277
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-17
- Primary completion
- 2012-12-28
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.